KRYS
HEALTHCAREKrystal Biotech Inc
$288.99+4.42 (+1.55%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving KRYS Today?
No stock-specific AI insight has been generated for KRYS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$122.80$303.00
$288.99
Fundamentals
Market Cap$8.5B
P/E Ratio38.7
EPS$7.46
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.5%
Debt / Equity—
Trading
Volume289K
Avg Volume (10D)—
Shares Outstanding29.5M
KRYS News
20 articles- Krystal Biotech to Present at BofA Securities 2026 Health Care ConferenceYahoo Finance·May 7, 2026
- Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in FocusYahoo Finance·May 5, 2026
- A Look At Krystal Biotech (KRYS) Valuation After Recent Share Price MomentumYahoo Finance·May 5, 2026
- Krystal Biotech, Inc. Q1 2026 Earnings Call SummaryMoby·May 4, 2026
- Krystal (KRYS) Q1 2025 Earnings TranscriptMotley Fool·May 4, 2026
- Krystal Biotech Q1 Earnings Call HighlightsMarketbeat·May 4, 2026
- Krystal Biotech, Inc. (KRYS) Tops Q1 Earnings and Revenue EstimatesYahoo Finance·May 4, 2026
- Krystal Biotech Announces First Quarter 2026 Financial and Operating ResultsYahoo Finance·May 4, 2026
- How The Krystal Biotech (KRYS) Narrative Is Shifting With Vyjuvek And Late Stage PipelineYahoo Finance·May 2, 2026
- Is Paymentus Stock a Buy After Palisades Investment Partners Increased Its Stake By $6 Million?Motley Fool·May 1, 2026
- Is Amprius Technologies Stock a Buy After Palisades Investment Partners Initiated a Position Worth $4.8 Million?Motley Fool·May 1, 2026
- Palisades Investment Partners Initiated a Position in SkyWater Technology Stock. What Does This Mean for Investors?Motley Fool·May 1, 2026
- Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·Apr 30, 2026
- Krystal Biotech to Present at Upcoming Scientific ConferencesYahoo Finance·Apr 30, 2026
- High Growth Tech Stocks To Watch In The US April 2026Yahoo Finance·Apr 29, 2026
- Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseYahoo Finance·Apr 27, 2026
- Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026Yahoo Finance·Apr 21, 2026
- 3 Under-the-Radar Healthcare Stocks Worth Adding to Your WatchlistMotley Fool·Apr 16, 2026
- Is Vertex Pharmaceuticals' Empire in Trouble?Motley Fool·Apr 16, 2026
- Could This Under-the-Radar Healthcare Stock Set You Up for Life?Motley Fool·Apr 7, 2026
All 20 articles loaded
Price Data
Open$286.28
Previous Close$284.57
Day High$290.00
Day Low$280.10
52 Week High$303.00
52 Week Low$122.80
52-Week Range
$122.80$303.00
$288.99
Fundamentals
Market Cap$8.5B
P/E Ratio38.7
EPS$7.46
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.5%
Debt / Equity—
Trading
Volume289K
Avg Volume (10D)—
Shares Outstanding29.5M
About Krystal Biotech Inc
Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United States. The company is headquartered in Pittsburgh, Pennsylvania.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—